Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $33,557
41%  
Woo hoo!! And we're now over 41%!! Thank you all very much!! God bless.

Keyword: 15usc

Brevity: Headers | « Text »
  • Oh, It's Not A Racket? (Pharmacology)

    05/09/2016 7:13:29 AM PDT · by SatinDoll · 87 replies
    The Market-Ticker ^ | May 9, 2016 | Karl Denninger
    Oh yes it is. "My parents were just vacationing in Europe (they go often so they're aware of how stuff works). My mom is diabetic and had a shortage of insulin while in France, they went to the drugstore and she showed the bottle of Humalog which is what she uses in the United States and the price in the United States is around $240 a bottle which is charged to her Medicare and insurance and can only be prescribed by her doctor." "The pharmacist recognized the bottle and without having to go to a doctor sold her a bottle...
  • Vote For Trump, Go Broke, Or Die

    03/03/2016 4:24:04 AM PST · by SatinDoll · 42 replies
    The Market-Ticker ^ | March 3, 2016 | Karl Denninger
    I know, the headline sounds dramatic. It's true. Trump has just released his health care reform proposal. He is the only candidate that has put forward a plan that will force down the cost of medical care by as much as 80%, rendering Obamacare unnecessary along with Medicare. Require price transparency from all healthcare providers, especially doctors and healthcare organizations like clinics and hospitals. Individuals should be able to shop to find the best prices for procedures, exams or any other medical-related procedure. .... Remove barriers to entry into free markets for drug providers that offer safe, reliable and cheaper...
  • The Answer Is Quite Simple, But Nobody Will Pick Up The Ball

    09/23/2015 8:59:46 AM PDT · by SatinDoll · 49 replies
    The Market-Ticker ^ | Sept. 23, 2015 | Karl Denninger
    C'mon folks, this isn't complicated. Hill used Indian government data on the cost of pharmaceutical ingredients and allowed for a 50-percent profit margin - but no money for investment in research - to work out the costs of producing certain drugs. On this basis, he found that Novartis' leukaemia drug Glivec actually cost $159 for a year's treatment, against the $106,000 charged in the United States. Roche's Tarceva for lung cancer cost $236, against a U.S. price of $79,000, and Novartis' Tykerb cost $4,000 against a price of $74,000. In all these cases the U.S. cost was far above that...